Literature DB >> 19135549

Target discovery from data mining approaches.

Yongliang Yang1, S James Adelstein, Amin I Kassis.   

Abstract

Data mining of available biomedical data and information has greatly boosted target discovery in the 'omics' era. Target discovery is the key step in the biomarker and drug discovery pipeline to diagnose and fight human diseases. In biomedical science, the 'target' is a broad concept ranging from molecular entities (such as genes, proteins and miRNAs) to biological phenomena (such as molecular functions, pathways and phenotypes). Within the context of biomedical science, data mining refers to a bioinformatics approach that combines biological concepts with computer tools or statistical methods that are mainly used to discover, select and prioritize targets. In response to the huge demand of data mining for target discovery in the 'omics' era, this review explicates various data mining approaches and their applications to target discovery with emphasis on text and microarray data analysis. Two emerging data mining approaches, chemogenomic data mining and proteomic data mining, are briefly introduced. Also discussed are the limitations of various data mining approaches found in the level of database integration, the quality of data annotation, sample heterogeneity and the performance of analytical and mining tools. Tentative strategies of integrating different data sources for target discovery, such as integrated text mining with high-throughput data analysis and integrated mining with pathway databases, are introduced.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19135549     DOI: 10.1016/j.drudis.2008.12.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  28 in total

1.  Has discovery-based cancer research been a bust?

Authors:  R J Epstein
Journal:  Clin Transl Oncol       Date:  2013-09-04       Impact factor: 3.405

Review 2.  Positron emission tomography imaging of cancer biology: current status and future prospects.

Authors:  Kai Chen; Xiaoyuan Chen
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

Review 3.  miRNAs target databases: developmental methods and target identification techniques with functional annotations.

Authors:  Nagendra Kumar Singh
Journal:  Cell Mol Life Sci       Date:  2017-02-15       Impact factor: 9.261

Review 4.  Principles of early drug discovery.

Authors:  J P Hughes; S Rees; S B Kalindjian; K L Philpott
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

5.  The power of the web in cancer drug discovery and clinical trial design: research without a laboratory?

Authors:  Christine Galustian; Angus G Dalgleish
Journal:  Cancer Inform       Date:  2010-02-18

6.  Identification and optimization of classifier genes from multi-class earthworm microarray dataset.

Authors:  Ying Li; Nan Wang; Edward J Perkins; Chaoyang Zhang; Ping Gong
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

Review 7.  Rethinking drug design in the artificial intelligence era.

Authors:  Petra Schneider; W Patrick Walters; Alleyn T Plowright; Norman Sieroka; Jennifer Listgarten; Robert A Goodnow; Jasmin Fisher; Johanna M Jansen; José S Duca; Thomas S Rush; Matthias Zentgraf; John Edward Hill; Elizabeth Krutoholow; Matthias Kohler; Jeff Blaney; Kimito Funatsu; Chris Luebkemann; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2019-12-04       Impact factor: 84.694

Review 8.  Design and development of molecular imaging probes.

Authors:  Kai Chen; Xiaoyuan Chen
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

9.  Effects of protein interaction data integration, representation and reliability on the use of network properties for drug target prediction.

Authors:  Antonio Mora; Ian M Donaldson
Journal:  BMC Bioinformatics       Date:  2012-11-12       Impact factor: 3.169

10.  Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.

Authors:  Premkumar Jayaraman; Kishore R Sakharkar; ChuSing Lim; Mohammad Imran Siddiqi; Sarinder K Dhillon; Meena K Sakharkar
Journal:  Drug Des Devel Ther       Date:  2013-06-17       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.